Pricing Log in Create free account

LENZ Therapeutics, Inc. (LENZ) vs OnKure Therapeutics, Inc. (OKUR)

LENZ Therapeutics, Inc. and OnKure Therapeutics, Inc. are both Biotechnology companies. LENZ Therapeutics, Inc. and OnKure Therapeutics, Inc. are of similar size ($102.3M and $94.6M). OnKure Therapeutics, Inc. has the higher net margin (0.00% vs −1,135.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, OnKure Therapeutics, Inc. leads on 10 and LENZ Therapeutics, Inc. on 3.

Valuation

Metric LENZ OKUR Biotechnology median
P/E n/m n/m 10.26
P/S 7.73 n/m 9.18
P/B 0.50 0.73 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.67 0.82 0.65
EV/Sales (8.06) n/m 8.98
Earnings yield (147.55%) (138.34%) (34.89%)
Free cash flow yield (133.70%) (37.94%) (24.52%)

Profitability

Metric LENZ OKUR Biotechnology median
Gross margin 85.35% 0.00% 65.16%
Operating margin (1,211.17%) 0.00% 0.00%
Net margin (1,134.97%) 0.00% 0.00%
Free cash flow margin (1,033.28%) 0.00% 0.00%
Return on equity (72.69%) (46.91%) (50.12%)
Return on assets (66.72%) (44.24%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LENZ OKUR Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) (21.79%) 71.20% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LENZ OKUR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.66 26.75 4.89
Net debt to EBITDA 3.22 0.95 1.01

Dividend

Metric LENZ OKUR Biotechnology median
Dividend yield 0.00% — 0.41%
Payout ratio — — —

Size

Metric LENZ OKUR Biotechnology median
Market cap 94.58m 102.26m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack